Cutis strengthens skin barrier for longevity
Reborn SkinBiome™ platform uses beneficial bacteria and postbiotics to reinforce barrier, reduce inflammation, and suppress pathogens without antibiotics.
See the latest news and media coverage for Cutis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Inactive skin microbiome biotechnology company
cutis.seLast updated
In short: Cutis advanced microbiome skincare, joined Sting, prepared for SLUSH 2025, and launched a CBD range.
Reborn SkinBiome™ platform uses beneficial bacteria and postbiotics to reinforce barrier, reduce inflammation, and suppress pathogens without antibiotics.
They use genomics and assays to identify beneficial bacteria strains and postbiotics that suppress pathogens, reduce inflammation, and strengthen skin barriers without antibiotics.
The acceptance provides access to investors, coaches, and experts. It supports Cutis in revolutionizing skin health through the microbiome.
The biotechnology platform uses live commensal bacteria to restore skin resilience, based on research from Karolinska Institutet and four core pillars. Cutis seeks partnerships.
Track Cutis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.